Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05252390
Title NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio Inc.
Indications

prostate cancer

Advanced Solid Tumor

ovarian cancer

peritoneum cancer

fallopian tube cancer

pancreatic cancer

triple-receptor negative breast cancer

Therapies

NUV-868

NUV-868 + Olaparib

Enzalutamide + NUV-868

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore Maryland 21224 United States Details
Karmanos Cancer Institute Recruiting Detroit Michigan 48201 United States Details
Carolina BioOncology Institute Recruiting Huntersville North Carolina 28078 United States Details
Sarah Cannon Research Institute - Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Recruiting Dallas Texas 75230 United States Details
Center for Oncology and Blood Disorders Recruiting Houston Texas 77030 United States Details
NEXT Virginia Recruiting Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field